[ 1 ]Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion

[ 2 ]Identification and evaluation of a lipid-lowering small compound in preclinical models and in a Phase I trial

[ 3 ]Lysosomal integral membrane protein-2 (LIMP-2/SCARB2) is involved in lysosomal cholesterol export

[ 4 ]New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice

[ 5 ]Chem-Stamp Empowered Discovery of a Novel ATRA-Based LDLR Up-Regulator for the Treatment of Atherosclerosis

[ 6 ]PAQR3 modulates blood cholesterol level by facilitating interaction between LDLR and PCSK9

[ 7 ]Fatostatin inhibits SREBP2-mediated cholesterol uptake via LDLR against selective estrogen receptor α modulator-induced hepatic lipid accumulation

[ 8 ]SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1

[ 9 ]Ascorbic acid enhances low-density lipoprotein receptor expression by suppressing proprotein convertase subtilisin/kexin 9 expression

[ 10 ]Hepatocyte-Targeted Cyclic Peptide LYTACs for PCSK9 Degradation and LDL Cholesterol Metabolic Regulation

[ 11 ]Comprehensive chemical profiling of the flowers of Citrus aurantium L. var. amara Engl. and uncovering the active ingredients of lipid lowering

[ 12 ]Abnormal Endocytosis Resulting from Imbalanced Proteomic Doses in Human Aneuploid Embryos